GMP-compliant automated synthesis and quality control of [177Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancer

Abstract Background Prostate cancer (PCa) has been identified as the most prevalent form of cancer among males and the third leading cause of death from cancer in the European male population. Early-stage PCa can be treated with prostatectomy and radiotherapy, whereas metastatic cases require androg...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Amélie Coussirou, Mélodie Six, Agathe Edet-Sanson, Alice Salles, Pierre Vera, David Tonnelet, Pierre Bohn
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	SpringerOpen 2026-05-01
Edice:	EJNMMI Radiopharmacy and Chemistry
Témata:	Prostate cancer Lutetium PSMA-I&T Radioligand therapy Experimental drug
On-line přístup:	https://doi.org/10.1186/s41181-026-00455-x
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!